Evunzekibart (ATOR-1017) is an Fc-gamma receptor-dependent 4-1BB agonist and an IgG4 isotype antibody that can act as a monotherapy or synergize with anti-PD1 therapies to enhance anti-tumor effects.
CAS Number:
[2639688-77-8]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted